Recall Record

Fairfield, NJ, United States

Datascope Corp. recalls

39 recalls recorded since 2018, most recently on 6 February 2026. 32 are listed as ongoing. Status and classification are as published by the FDA.

Recalls39
Ongoing (FDA)32
Terminated or completed7
Class I (FDA)14

Ongoing Class III Medical devices

Recall started
6 February 2026
Reason
The Battery Charging Station is an optional dual-bay charger used to charge the Cardiosave IABP Lithium- Ion batteries when they are not being used to operate the IABP. Getinge has identified that a protruding screw in the left battery bay limits full insertion of certain batteries and prevents proper charging. The right bay of the Battery Charging Station is not affected by this issue.
Distribution
Worldwide - US Nationwide distribution in the states of FL, DC, GA, IL, IN, MD, MI, NC, TX, WA, WI and the countries of Australia, Hong Kong, Israel, Japan, Norway.
Initiated
Voluntary: Firm initiated
Recall number
Z-1587-2026

Ongoing Class II Medical devices

Recall started
23 January 2026
Reason
The firm has identified that the battery runtime and cycle specifications contained in the devices Instructions for Use (IFU) need to be updated.
Distribution
Worldwide distribution - US Nationwide and the countries of Afghanistan, Albania, Algeria, Argentina, Australia, Austria, Azerbaijan, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Bolivia, Bosnia And Herzegovina, Brazil, Bulgaria, Cambodia, Canada, Chile, China, Colombia, Costa Rica, Cyprus, Czec
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1487-2026, Z-1486-2026

Ongoing Class II Medical devices

Recall started
4 November 2025
Reason
The IFU addendum revises the Preventative Maintenance schedule to align with the update introduced in the Service Manual as of June 2023.
Distribution
Domestic: Nationwide Distribution; Foreign: Albania, Algeria, Angola, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahrain, Bangladesh, Belarus, Belgium, Bosnia And Herzegovina, Botswana, Brazil, Brunei, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, C¿te d Ivoire, Croatia, Cyprus, Cze
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0917-2026, Z-0916-2026

Ongoing Class III Medical devices

Recall started
23 October 2025
Reason
The IFU addendum updates the Vibration and Shock Table to reference the correct standards.
Distribution
Domestic: Nationwide distribution. International: Albania, Algeria, Angola, Argentina, Armenia, Republic of, Australia, Austria, Azerbaijan, Bahrain, Bangladesh, Belarus, Belgium, Bosnia And Herzegovina, Botswana, Republic of, Brazil, Brunei, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, C¿
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0932-2026, Z-0931-2026

Ongoing Class II Medical devices

Recall started
17 September 2024
Reason
There is discrepant labeling on the inner and outer packaging of the device.
Distribution
International distribution to the countries of Germany, Spain , Finland, Great Britain, Hong Kong, Ireland, Italy, Lithuania, Moldova, Mexico, Norway, New Zealand, Poland, Sweden, Singapore.
Initiated
Voluntary: Firm initiated
Recall number
Z-0311-2025

Ongoing Class I Medical devices

Recall started
8 August 2024
Reason
Firm has developed a software correction (Revision D.00) outside the US to mitigate product problems that pose a risk of hemodynamic instability and failure of transmission of clinical data in Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic Balloon Pump devices.
Distribution
International distribution to the countries of UNITED ARAB EMIRATES, ARGENTINA , AUSTRIA, AUSTRALIA, BELGIUM, BULGARIA, BAHRAIN, BRAZIL, CANADA, SWITZERLAND, CHILE, CHINA, COLOMBIA, CZECH REPUBLIC, GERMANY, DENMARK, ECUADOR, EGYPT, SPAIN, FINLAND, FRANCE, UNITED KINGDOM, INDONESIA, IRELAND, INDIA, I
Initiated
Voluntary: Firm initiated
Recall numbers
Z-3134-2024, Z-3135-2024

Ongoing Class I Medical devices

Recall started
8 August 2024
Reason
Firm has developed a software correction (Revision D.01) for outside the US to mitigate product problems that pose a risk of hemodynamic instability and failure of transmission of clinical data in Cardiosave Hybrid and Cardiosave Rescue Intra-Aortic Balloon Pump devices.
Distribution
International distribution to the countries of UNITED ARAB EMIRATES, ARGENTINA , AUSTRIA, AUSTRALIA, BELGIUM, BULGARIA, BAHRAIN, BRAZIL, CANADA, SWITZERLAND, CHILE, CHINA, COLOMBIA, CZECH REPUBLIC, GERMANY, DENMARK, ECUADOR, EGYPT, SPAIN, FINLAND, FRANCE, UNITED KINGDOM, INDONESIA, IRELAND, INDIA, I
Initiated
Voluntary: Firm initiated
Recall numbers
Z-3137-2024, Z-3136-2024

Ongoing Class I Medical devices

Recall started
31 July 2023
Reason
Users were reporting that the device was not charging as expected. It was discovered that users were unaware that the Cardiosave console was not completely inserted into the hospital cart. If the console is not fully inserted back into the cart the battery(ies) will not charge.
Distribution
Worldwide - US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2431-2023, Z-2432-2023

Ongoing Class I Medical devices

Recall started
31 July 2023
Reason
Users were reporting instances of "Gas Loss in IAB Circuit" and "Gas Gain in IAB Circuit" alarms while providing therapy. An internal investigation of the complaints determined that there is a potential trigger for these alarms that was not listed in the IFU: Patient Movement (coughing, general movement, and swallowing). Blood in the circuit, kins and abrasions of the tubing/catheter and certain patient conditions could also trigger these alarms. The HHE also identified hardware issues related to these alarms.
Distribution
Worldwide - US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2435-2023, Z-2436-2023

Ongoing Class I Medical devices

Recall started
31 July 2023
Reason
Users reported "System Over Temperature" alarms associated with a loss of pumping and/or the Cardiosave system entering Standby mode.
Distribution
Worldwide - US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2433-2023, Z-2434-2023

Ongoing Class I Medical devices

Recall started
31 July 2023
Reason
Users were identifying autofill failure conditions on the devices causing pump stops.
Distribution
Worldwide - US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2438-2023, Z-2437-2023

Ongoing Class II Medical devices

Recall started
31 July 2023
Reason
Users were experiencing a failure in the IAB Fiber Optic Sensor input on the IABP when inserting the Intra-Aortic Balloon Fiber Optic connector.
Distribution
US Nationwide. Global Distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2487-2023, Z-2486-2023

Ongoing Class II Medical devices

Recall started
23 June 2023
Reason
During IAB catheter insertion, the introducer dilator may fracture at the hub, leaving the body of the introducer dilator housed within the sheath. Risks to health include damage to the femoral artery, descending aorta, or embolization; surgical intervention and delay of IAB therapy may also result. Firm has received 10 complaints, including 3 serious adverse events and 1 patient death.
Distribution
Domestic distribution nationwide. International distribution worldwide.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2223-2023, Z-2217-2023, Z-2216-2023, Z-2221-2023, Z-2218-2023, Z-2219-2023, Z-2224-2023, Z-2220-2023, Z-2222-2023

Ongoing Class I Medical devices

Recall started
5 June 2023
Reason
IABP may lose the ability to charge batteries in one or both bay slots. Therapy may be interrupted if batteries fail to charge and the device is disconnected from AC power. Low battery alarms may alert the User to the issue prior to interruption of therapy.
Distribution
Worldwide Distribution: US (Nationwide) and OUS (foreign) to countries of: ALBANIA ALGERIA, ANGOLA, ARGENTINA, AUSTRALIA, AUSTRIA, AZERBAIJAN, BAHRAIN, BANGLADESH, BARBADOS, BELARUS, BELGIUM, BOSNIA and HERZEGOVINA, BRAZIL, BRUNEI, BULGARIA, CANADA, CHILE, CHINA, COLOMBIA, COSTA RICA, C¿te d'Ivoire,
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2149-2023, Z-2150-2023

Ongoing Class I Medical devices

Recall started
5 June 2023
Reason
An unexpected shutdown of the IABP may occur due to failures of tantalum capacitors in the Power Management Board and/or Solenoid Board. This issue may lead to an unexpected interruption of therapy.
Distribution
Worldwide Distribution- US (Nationwide) and OUS (foreign) countries of: ALBANIA, ALGERIA, ANGOLA, ARGENTINA, AUSTRALIA, AUSTRIA, AZERBAIJAN, AZERBAIJAN , BAHRAIN, BANGLADESH, BARBADOS, BELARUS, BELGIUM, BOSNIA and HERZEGOVINA, BRAZIL, BRUNEI, BULGARIA, CANADA, CHILE, CHINA, COLOMBIA, COSTA RICA, C¿t
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2151-2023, Z-2152-2023

Ongoing Class III Medical devices

Recall started
4 May 2023
Reason
The digital IFUs provided with the Cardiosave IABP during the software update to version D.00 incorrectly annotated compliance to standard 60601-1-12:2014 within the updated IFU.
Distribution
International distribution in the country of Germany.
Initiated
Voluntary: Firm initiated
Recall number
Z-1907-2023

Ongoing Class II Medical devices

Recall started
4 April 2023
Reason
The power cord supplied (Type J plug end) for the Cardiosave Hybrid IABP to Brazil is incompatible with the Brazilian Type N power receptacle.
Distribution
International distribution in the country of Brazil.
Initiated
Voluntary: Firm initiated
Recall number
Z-1462-2023

Ongoing Class II Medical devices

Recall started
28 February 2023
Reason
There is an issue related to the Safety Disk not meeting a performance requirement that may impact Intra-Aortic Balloon catheter (IAB) displacement volume. This potential failure of an impacted Safety Disk may lead to slightly reduced IAB inflation during therapy or a reduction in the degree of augmentation provided to the patient during therapy.
Distribution
Distribution list not yet provided.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1277-2023, Z-1276-2023, Z-1278-2023, Z-1279-2023

Ongoing Class II Medical devices

Recall started
7 February 2023
Reason
There have been reported failures of the high pressure helium regulator, which may cause a helium leak in the Cardiosave Hospital Cart. In instance of helium regulator failure, a Pump Console s internal reservoir of helium will not be replenished when docked into an impacted Hospital Cart. This may result in an insufficient amount of helium within the internal reservoir.
Distribution
US Nationwide. Global Distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1230-2023, Z-1229-2023

Ongoing Class II Medical devices

Recall started
7 February 2023
Reason
Firm has received reports of damaged, worn, or torn O-rings on the Cardiosave Pump Console quick disconnect fitting, which results in helium tank leaks. If the helium supply is depleted, therapy will be interrupted.
Distribution
Nationwide US distribution. Worldwide international distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1231-2023, Z-1232-2023

Ongoing Class I Medical devices

Recall started
7 February 2023
Reason
An unexpected shutdown of the IABP may occur due to loss of communication between the Executive Processor PCBA and the Video Generator PCBA. This may result in an interruption to therapy which may threaten the hemodynamic stability of the supported patient as the user is left unaware to the status of the Cardiosave IABP.
Distribution
Worldwide Distribution: US (nationwide) including states of: AK, AL, AR, AZ, CA, CO, CT, DC, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NY, NV, OH, OK, OR, PA, SC, SD, TN, TX, VA, WA, WI, and WV; and OUS (Foreign) countries of: ALBANIA, ALGERIA, ANGO
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1147-2023, Z-1148-2023

Ongoing Class I Medical devices

Recall started
7 February 2023
Reason
An unexpected shutdown of the IABP may occur due to a failure of the connection between the Coiled Cord cable and the Cable Assembly backplane to the Coiled Cord cable which provides the communication between the display head and base unit.
Distribution
Worldwide Distribution: US (nationwide) and OUS (Foreign) ARGENTINA, AUSTRALIA, AUSTRIA, AZERBAIJAN, BAHRAIN, BELARUS, BELGIUM, BRAZIL, BRUNEI , BULGARIA, CANADA, CHILE, CHINA, CZECH REPUBLIC, ECUADOR, EGYPT, EL SALVADOR, FINLAND, FRANCE, GERMANY, GHANA, HONG KONG, ICELAND, INDIA, INDONESIA, IRAN, I
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1146-2023, Z-1145-2023

Ongoing Class I Medical devices

Recall started
19 December 2022
Reason
The Cardiosave IABP may shut down unexpectedly due to blood entering in the Cardiosave IABP when therapy is provided with a compromised intra-aortic balloon catheter.
Distribution
Worldwide Distribution - US Nationwide and the countries of Albania, Angola, Argentina, Australia, Austria, AZERBAIJAN, BAHRAIN, BANGLADESH, Barbados, Belarus, Belgium, BOSNIA and HERZEGOVINA, Brazil, Brunei, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, C¿te d'Ivoire, Croatia, CZECH REPUBLI
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0885-2023, Z-0886-2023

Ongoing Class II Medical devices

Recall started
5 August 2022
Reason
The balloon volume is incorrectly described as 34cc instead of 40cc on one of the three internal labels enclosed for hospital use. A labelling error may result in user confusion and/or delay in initiating therapy. Therapy delays may impact those patients who are more hemodynamically unstable.
Distribution
No US distribution. Foreign distribution to Argentina, Brazil, Canada, Chile, Columbia, Ecuador, Egypt, France, Indonesia, Israel, Italy, Jordan, Kenya, Malaysia, Mexico, Netherlands, Pakistan, Poland, Portugal, South Korea, Russia, Spain, Turkmenistan, United Arab Emirates, United Kingdom, Uruguay.
Initiated
Voluntary: Firm initiated
Recall number
Z-0131-2023

Ongoing Class II Medical devices

Recall started
5 August 2022
Reason
Certain lots containing undersized dilator.
Distribution
Awaiting domestic distribution. Foreign: Australia, Belgium, Canada, Czech Republic, France, Germany, Hong Kong, Iceland, Ireland, Italy, Netherlands, New Zealand, Norway, Poland, Portugal, Saudi Arabia, Slovenia, South Africa, Spain, Sweden, Switzerland, United Arab Emirates, United Kingdom.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1685-2022, Z-1686-2022, Z-1687-2022

Ongoing Class I Medical devices

Recall started
15 November 2021
Reason
Firm is initiating a correction due to the possibility of fluid ingress. Fluid entering the device may short various electronic components thus leading to system shutdown, which could result in unsafe hemodynamic instability.
Distribution
Worldwide distribution - US Nationwide.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0337-2022, Z-0336-2022

Ongoing Class I Medical devices

Recall started
21 September 2021
Reason
A Cardiosave Lithium-Ion Battery Pack used during protocol testing failed to meet the minimum runtime requirement per Getinge internal Product Specification. These nonconforming batteries were inadvertently released to customers.
Distribution
Worldwide distribution. US nationwide, Australia, Brazil, Bahrain, Belgium, Canada, China, Czech Republic, Egypt, France, Germany, India, Ireland, Italy, Japan, Kuwait, Netherlands, Norway, Pakistan, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, T
Initiated
Voluntary: Firm initiated
Recall number
Z-0091-2022

Ongoing Class II Medical devices

Recall started
8 September 2021
Reason
The Cardiosave IABP may unexpectedly shut down when the device is running on AC power, only one battery is installed in the IABP, and the battery is physically removed while the battery is being charged. This occurs during a very specific set of conditions.
Distribution
Nationwide domestic distribution. Foreign distribution worldwide.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2615-2021, Z-2616-2021

Ongoing Class II Medical devices

Recall started
8 September 2021
Reason
The Helium Indicator on the Cardiosave display may over represent the amount of helium in unit in the presence of Electromagnetic Interference.
Distribution
Worldwide distribution - US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0075-2022, Z-0076-2022

Ongoing Class III Medical devices

Recall started
22 March 2021
Reason
There are cybersecurity vulnerabilities in a widely used low-level TCP/IP software library that may result in a loss of communication to the Hospital Information System/Clinical Information System (HIS/CIS).
Distribution
Worldwide distribution - US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1507-2021, Z-1506-2021

Ongoing Class II Medical devices

Recall started
27 July 2020
Reason
Potential Endotoxin Contamination
Distribution
Worldwide distribution - US Nationwide distribution and the countries of Argentina, Austrailia Austria Belgium Brazil Canada Chile Colombia Czech Republic Denmark Finland France Germany Hong Kong India Ireland Italy Japan Korea Mexico Netherlands New Zealand Norway Paraguay Poland Portugal Russia, S
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2839-2020, Z-2842-2020, Z-2843-2020, Z-2833-2020, Z-2837-2020, Z-2838-2020, Z-2846-2020, Z-2831-2020, Z-2847-2020, Z-2841-2020, Z-2832-2020, Z-2845-2020 and 5 more

Terminated Class II Medical devices

Recall started
20 November 2019
Terminated
15 June 2021
Reason
Potential for compromised sterility in breached pouches of specific lots of Reinforced Introducer Sets Maquet 7 Fr., 7.5 Fr. and 8 Fr. IABs.
Distribution
US: AK AL AZ CA CO CT FL GA IA ID IL IN KS KY LA MD MI MN MO MS NC ND NE NJ NY OH OK PA SC SD TN TX VA WA WI WV OUS: Switzerland, Netherlands, South Africa, Canada, Germany, Austria, Spain, Italy, Poland, Bharain, Malaysia
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0934-2020, Z-0932-2020, Z-0933-2020

Terminated Class II Medical devices

Recall started
3 October 2019
Terminated
8 January 2021
Reason
One lot of "Low Level Output Cable - Interface to Philips Monitor" was received from the supplier with an incorrect cable in the packaging.
Distribution
Distributed to CA, GA, and TX.
Initiated
Voluntary: Firm initiated
Recall number
Z-0266-2020

Ongoing Class I Medical devices

Recall started
17 June 2019
Reason
If battery maintenance is not performed appropriately, the battery may provide less than the minimum run time of operating power. Revised labeling and training are being provided.
Distribution
Worldwide distribution. US Nationwide, AFGHANISTAN , HUNGARY , PANAMA , ALGERIA , ICELAND , PARAGUAY , ARGENTINA , INDIA , PERU , AUSTRALIA , INDONESIA , PHILIPPINES , AUSTRIA , IRAN , POLAND , AZERBAIJAN , IRAQ , PORTUGAL , BAHRAIN , IRELAND , QATAR , BANGLADESH , ISRAEL , ROMANIA , BELARUS , ITALY
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1942-2019, Z-1941-2019, Z-1944-2019, Z-1939-2019, Z-1943-2019, Z-1940-2019

Terminated Class II Medical devices

Recall started
28 May 2019
Terminated
25 September 2023
Reason
The device was distributed with the outer carton labeled with the manufacture date and the expiry date reversed. This showed the product as expired before it was manufactured.
Distribution
The products were distributed to the following US states: FL. The products were distributed to the following foreign countries: Australia, Austria, Belgium, Estonia, France, Germany, Ireland, Italy, Kuwait, Lithuania, Malaysia, Mexico, Netherlands, Poland, Russia, Saudi Arabia, Slovakia, Sweden
Initiated
Voluntary: Firm initiated
Recall number
Z-1966-2019

Terminated Class II Medical devices

Recall started
21 February 2018
Terminated
18 March 2020
Reason
The U.S. Instructions For Use for the Mega Intra-Aortic Balloon (IAB) Catheter was missing the Contraindications section.
Distribution
US Nationwide Distribution
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1384-2018, Z-1383-2018, Z-1385-2018

Terminated Class II Medical devices

Recall started
19 October 2017
Terminated
24 April 2020
Reason
The Better Bladder device provided as part of some custom tubing kits has been recalled by its manufacturer. Seal separation from the housing may allow air to enter the housing and collapse the balloon. This may increase resistance to flow in the venous line and cause a drop in ECMO circuit blood flow.
Distribution
Distributed to accounts in AL, AR, CA, DC, FL, IL, LA, MO, NC, PA, SC, TX, and WA.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1712-2018, Z-1729-2018, Z-1721-2018, Z-1728-2018, Z-1716-2018, Z-1708-2018, Z-1731-2018, Z-1727-2018, Z-1732-2018, Z-1709-2018, Z-1714-2018, Z-1719-2018 and 16 more

Terminated Class II Medical devices

Recall started
27 July 2017
Terminated
7 February 2020
Reason
There is a potential for the over-pressure safety (OPS) valve in the tubing kits to not allow flow through.
Distribution
The products were distributed to the following US states: IA and FL.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2178-2018, Z-2179-2018, Z-2180-2018

Terminated Class III Medical devices

Recall started
11 March 2016
Terminated
7 June 2019
Reason
There is a potential problem with the cuvette where failure of the cuvette would cause an error message on the monitor display of H/S DISCONNECT AT CUVETTE.
Distribution
The products were distributed to the following US states: AL, OR, and TX.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2106-2018, Z-2104-2018, Z-2105-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.